February 27-28, 2012, pharmaceutical company AO “Pharm-Sintez” participated in the IV International Congress “Neuro-Rehabilitation 2012” which was held in the in the Moscow City Government Building.
“New strategy for management of cases with brain vascular pathology” was the main direction of scientific agenda for the International congress “Neuro-Rehabilitation 2012”. Strategy included issues of early rehabilitation and secondary stroke prevention, special aspects of diagnostic, treatment and rehabilitation of patients with chronic cerebral ischemia:
Congress schedule included scientific plenary sessions, symposiums, educational workshops, research and practical interactive trainings and master classes.
Leading scientific, clinical and educational centers of Russian Academy of Medical Science, Russian Political Science Association, Ministry of Healthcare and Social Development of the Russian Federation took part in the congress.
During the conference there was exhibition of pharmaceutical products, devices for functional and in vitro diagnostic, rehabilitation equipment, patient care aids.
Congress participants showed great interest in the innovative neuroprotector Cellex manufactured by AO “Pharm-Sintez”, intended for treatment of stroke during acute and early rehabilitation stage. This year the product will enter commercial market.